These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1760641

  • 1. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation.
    Giorgiani G, Bozzola M, Cisternino M, Locatelli F, Gambarana D, Bonetti F, Zecca M, Lorini R, Severi F.
    Bone Marrow Transplant; 1991; 8 Suppl 1():53. PubMed ID: 1760641
    [No Abstract] [Full Text] [Related]

  • 2. Relative toxicity of two different conditioning regimens in patients undergoing allogeneic bone marrow transplantation.
    Romeiras M, Rodrigues AS, Machado A, Jorge L, Nolasco I, Abecasis M.
    Bone Marrow Transplant; 1991; 7 Suppl 2():133. PubMed ID: 1878678
    [No Abstract] [Full Text] [Related]

  • 3. [Endocrinal sequela in bone marrow transplantations during childhood and adolescence].
    Le Heup B, von Bueltzingloewen A, Bordigoni P, Sommelet D, Pierson M.
    Ann Pediatr (Paris); 1993 Sep; 40(7):463-8. PubMed ID: 8239398
    [Abstract] [Full Text] [Related]

  • 4. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
    Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF.
    Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
    [Abstract] [Full Text] [Related]

  • 5. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
    Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ.
    Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
    [Abstract] [Full Text] [Related]

  • 6. Busulfan as part of conditioning regimen for bone marrow transplantation in children.
    Nespoli L, Locatelli F, Zecca M.
    Bone Marrow Transplant; 1991 Sep; 8 Suppl 1():30-2. PubMed ID: 1760632
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
    Kalaycioglu ME, Bolwell BJ.
    Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ovarian function after bone marrow transplantation during childhood.
    Thibaud E, Rodriguez-Macias K, Trivin C, Espérou H, Michon J, Brauner R.
    Bone Marrow Transplant; 1998 Feb; 21(3):287-90. PubMed ID: 9489652
    [Abstract] [Full Text] [Related]

  • 13. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg).
    Grigg AP, McLachlan R, Zaja J, Szer J.
    Bone Marrow Transplant; 2000 Nov; 26(10):1089-95. PubMed ID: 11108308
    [Abstract] [Full Text] [Related]

  • 14. Successful pregnancy in a 28-year-old patient autografted for acute lymphoblastic leukemia following myeloablative treatment including total body irradiation.
    Samuelsson A, Fuchs T, Simonsson B, Björkholm M.
    Bone Marrow Transplant; 1993 Dec; 12(6):659-60. PubMed ID: 8136750
    [Abstract] [Full Text] [Related]

  • 15. [Gonadal function in adolescents after total body irradiation in bone marrow transplantation].
    Gambarana D, Tonani P, Bongiorno M, Focardi C, Biscaldi I, Cerbo RM.
    Medicina (Firenze); 1990 Dec; 10(2):152-4. PubMed ID: 2125679
    [Abstract] [Full Text] [Related]

  • 16. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
    Tutschka PJ.
    Bone Marrow Transplant; 1993 Dec; 12 Suppl 1():34-6. PubMed ID: 8374557
    [No Abstract] [Full Text] [Related]

  • 17. Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
    Cheng YC, Saliba RM, Rondón G, Giralt SA, Lu KH, Bodurka DC, Gershenson DM, Champlin RE, Ueno NT.
    Haematologica; 2005 Dec; 90(12):1725-6. PubMed ID: 16330461
    [Abstract] [Full Text] [Related]

  • 18. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants.
    Al-Fiar FZ, Colwill R, Lipton JH, Fyles G, Spaner D, Messner H.
    Bone Marrow Transplant; 1997 May; 19(10):1019-22. PubMed ID: 9169646
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.